Craif

Tokyo, Japan · Founded 2018 · Privately Held (backing)

Provider of exosome-based liquid biopsy tests intended to provide accurate and painless early cancer detection. Craif is based in Tokyo, Japan and was founded in 2018. Its last reported valuation was $75 million in Apr 2022. It has raised $42.5 million.

Last reported valuation
$75.0M
Oct 2026
Priced at
—
Total raised
$42.5M
Last round
—

Who backs Craif?

33 investors
InvestorType
Plug and Play Tech Center—
MedTech InnovatorOther
Global BrainVenture capital
Founders FundVenture capital
ANRIVenture capital
Aozora Corporate InvestmentOther
Hakuhodo DY VenturesOther
Daiwa Corporate InvestmentAsset manager
Unreasonable GroupOther
Tokio Marine & Nichido Fire InsuranceOther
+ 23 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Craif investors

33 investors are on record for Craif, including Plug and Play Tech Center, MedTech Innovator, Global Brain and Founders Fund. By type, the record holds 4 venture capital firms and 1 asset manager.

Free account
More of Craif with a free account
  • ·The complete investor list: 33 names
  • ·Watch Craif: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 33 firms already write checks for companies like Craif. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View